Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis [ATAC-Seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 74 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 74 samples: 20 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE279088_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1170339 and SRA study SRP537210. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 68 samples.
How we read this: 20 replicated groups read from 74 sample titles; they account for 68 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8561172 d2_KrasG12D_Caerulein_B2104 d2_KrasG12D_Caerulein_B
- GSM8561173 d2_KrasG12D_Caerulein_B2106 d2_KrasG12D_Caerulein_B
- GSM8561174 d2_KrasG12D_Caerulein_B2242 d2_KrasG12D_Caerulein_B
- GSM8561175 d2_KrasG12D_Caerulein_B2243 d2_KrasG12D_Caerulein_B
- GSM8561176 d2_KrasG12R_Caerulein_B2066 d2_KrasG12R_Caerulein_B
- GSM8561177 d2_KrasG12R_Caerulein_B2067 d2_KrasG12R_Caerulein_B
- GSM8561178 d2_KrasG12R_Caerulein_B2257 d2_KrasG12R_Caerulein_B
- GSM8561179 d2_KrasG12R_Caerulein_B2260 d2_KrasG12R_Caerulein_B
- GSM8561180 d2_KrasG12Vgeo_Caerulein_B2057 d2_KrasG12Vgeo_Caerulei…
- GSM8561181 d2_KrasG12Vgeo_Caerulein_B2059 d2_KrasG12Vgeo_Caerulei…
- GSM8561182 d2_KrasG12Vgeo_Caerulein_B2165 d2_KrasG12Vgeo_Caerulei…
- GSM8561183 d2_KrasG12Vgeo_Caerulein_B2167 d2_KrasG12Vgeo_Caerulei…
- GSM8561184 d2_KrasWT_Caerulein_B2058 d2_KrasWT_Caerulein_B
- GSM8561185 d2_KrasWT_Caerulein_B2068 d2_KrasWT_Caerulein_B
- GSM8561186 d2_KrasWT_Caerulein_B2259 d2_KrasWT_Caerulein_B
- GSM8561187 d2_KrasWT_Caerulein_B2261 d2_KrasWT_Caerulein_B
- GSM8561188 ductal1 ductal
- GSM8561189 ductal2 ductal
- GSM8561190 ductal3 ductal
- GSM8561191 ductal4 ductal
- GSM8561192 earlyProgenitor_PT42A_1_2
- GSM8561193 earlyProgenitor_PT42A_2_1 earlyProgenitor_PT42A_2
- GSM8561194 earlyProgenitor_PT42A_2_2 earlyProgenitor_PT42A_2
- GSM8561195 earlyProgenitor_PT42A-1
- GSM8561196 earlyProgenitor_PT43A_1_1 earlyProgenitor_PT43A_1
- GSM8561197 earlyProgenitor_PT43A_1_2 earlyProgenitor_PT43A_1
- GSM8561198 earlyProgenitor_PT43A_2_1 earlyProgenitor_PT43A_2
- GSM8561199 earlyProgenitor_PT43A_2_2 earlyProgenitor_PT43A_2
- GSM8561200 lateProgenitor_PT27B-2
- GSM8561201 lateProgenitor_PT38B-1
- GSM8561202 lateProgenitor_PT39B-1 lateProgenitor_PT39B
- GSM8561203 lateProgenitor_PT39B-2 lateProgenitor_PT39B
- GSM8561204 wk3_KrasG12D_Caerulein_B0107 wk3_KrasG12D_Caerulein_B
- GSM8561205 wk3_KrasG12D_Caerulein_B0109 wk3_KrasG12D_Caerulein_B
- GSM8561206 wk3_KrasG12D_Caerulein_B0511 wk3_KrasG12D_Caerulein_B
- GSM8561207 wk3_KrasG12D_Caerulein_B0559 wk3_KrasG12D_Caerulein_B
- GSM8561208 wk3_KrasG12D_Caerulein_B0560 wk3_KrasG12D_Caerulein_B
- GSM8561209 wk3_KrasG12D_Caerulein_B0565 wk3_KrasG12D_Caerulein_B
- GSM8561210 wk3_KrasG12D_Saline_4911 wk3_KrasG12D_Saline
- GSM8561211 wk3_KrasG12D_Saline_4913 wk3_KrasG12D_Saline
+ 34 more — browse all 74 samples with per-sample file links →
- GSE279089 Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis [RNA-Seq] 76 samples shares kras, tumorigenesis, phenotypic, divergence, pancreatic, dynamics, driving
- GSE250099 KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56a to initiate pancreatic cancer development [ATAC-seq] 18 samples shares kras, pancreatic, atac-seq
- GSE299487 LY6D Identifies Persistent Tumor-Initiating Cells Driving Pancreatic Tumorigenesis [scRNA-seq] 12 samples shares tumorigenesis, pancreatic, driving
- GSE319596 Lineage identity governs oncogene dependence in murine NSCLC models of KRAS inhibitor resistance [ATAC-Seq] 16 samples shares kras, atac-seq
- GSE297058 Hereditary Chronic Pancreatitis Induced Plasticity Cooperates with Mutant Kras in Early Pancreatic Carcinogenesis 128 samples shares kras, pancreatic
- GSE301459 Elucidating the impact of KRAS Gly12 mutants on homeostasis and tumorigenesis in the colonic epithelium 24 samples shares kras, tumorigenesis
- GSE328371 KMT2D depletion promote KRAS-induced pancreatic carcinogenesis independent of TP53 24 samples shares kras, pancreatic
- GSE252839 Nuclear Factor NFAT5 Governs Cellular Plasticity-Induced KRAS-Targeted Therapy Resistance in Pancreatic Cancer 24 samples shares kras, pancreatic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.